<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7710969</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33329346</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7710969</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2020.593950</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and tumor related data.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic and tumor related data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Patient</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Age</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Gender</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Hand</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Tumor location</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Presenting symptom</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Tumor grade</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Genetics</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">L</td><td valign="top" align="left" rowspan="1" colspan="1">Left post-central</td><td valign="top" align="left" rowspan="1" colspan="1">Seizure</td><td valign="top" align="left" rowspan="1" colspan="1">Grade III Astrocytoma</td><td valign="top" align="left" rowspan="1" colspan="1">IDH mt, ATRX loss, MGMT methylated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">63</td><td valign="top" align="center" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left post-central</td><td valign="top" align="left" rowspan="1" colspan="1">Seizure</td><td valign="top" align="left" rowspan="1" colspan="1">GBM</td><td valign="top" align="left" rowspan="1" colspan="1">IDH WT, ATRX retained, p53 positive, MGMT unmethylated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">31</td><td valign="top" align="center" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left frontal</td><td valign="top" align="left" rowspan="1" colspan="1">Headache</td><td valign="top" align="left" rowspan="1" colspan="1">Grade III Astrocytoma</td><td valign="top" align="left" rowspan="1" colspan="1">IDH1 mt, ATRX loss, MGMT methylated, p53 positive</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">64</td><td valign="top" align="center" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left post-central</td><td valign="top" align="left" rowspan="1" colspan="1">Word finding difficulty, right hand sensory deficit</td><td valign="top" align="left" rowspan="1" colspan="1">GBM</td><td valign="top" align="left" rowspan="1" colspan="1">IDH WT, ATRX retained, MGMT methylated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left temporal</td><td valign="top" align="left" rowspan="1" colspan="1">Seizure</td><td valign="top" align="left" rowspan="1" colspan="1">Oligodendroglioma</td><td valign="top" align="left" rowspan="1" colspan="1">IDH mt, 1p/19q codeletion</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">32</td><td valign="top" align="center" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left frontal</td><td valign="top" align="left" rowspan="1" colspan="1">Seizure</td><td valign="top" align="left" rowspan="1" colspan="1">GBM</td><td valign="top" align="left" rowspan="1" colspan="1">IDH mutant, ATRX loss, MGMT methylated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">55</td><td valign="top" align="center" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left frontal</td><td valign="top" align="left" rowspan="1" colspan="1">Face numbness, right hand incoordination and dysarthria</td><td valign="top" align="left" rowspan="1" colspan="1">GBM</td><td valign="top" align="left" rowspan="1" colspan="1">IDH WT, p53 positive, MGMT methylated</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">F</td><td valign="top" align="center" rowspan="1" colspan="1">R</td><td valign="top" align="left" rowspan="1" colspan="1">Left frontal</td><td valign="top" align="left" rowspan="1" colspan="1">Seizure</td><td valign="top" align="left" rowspan="1" colspan="1">Grade II Astrocytoma</td><td valign="top" align="left" rowspan="1" colspan="1">IDH mt, ATRX loss, MGMT methylated</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and tumor related data.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Patient</th><th valign="top" align="center">Age</th><th valign="top" align="center">Gender</th><th valign="top" align="center">Hand</th><th valign="top" align="left">Tumor location</th><th valign="top" align="left">Presenting symptom</th><th valign="top" align="left">Tumor grade</th><th valign="top" align="left">Genetics</th></tr></thead><tbody><tr><td valign="top" align="left">1</td><td valign="top" align="center">46</td><td valign="top" align="center">M</td><td valign="top" align="center">L</td><td valign="top" align="left">Left post-central</td><td valign="top" align="left">Seizure</td><td valign="top" align="left">Grade III Astrocytoma</td><td valign="top" align="left">IDH mt, ATRX loss, MGMT methylated</td></tr><tr><td valign="top" align="left">2</td><td valign="top" align="center">63</td><td valign="top" align="center">F</td><td valign="top" align="center">R</td><td valign="top" align="left">Left post-central</td><td valign="top" align="left">Seizure</td><td valign="top" align="left">GBM</td><td valign="top" align="left">IDH WT, ATRX retained, p53 positive, MGMT unmethylated</td></tr><tr><td valign="top" align="left">3</td><td valign="top" align="center">31</td><td valign="top" align="center">M</td><td valign="top" align="center">R</td><td valign="top" align="left">Left frontal</td><td valign="top" align="left">Headache</td><td valign="top" align="left">Grade III Astrocytoma</td><td valign="top" align="left">IDH1 mt, ATRX loss, MGMT methylated, p53 positive</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="center">64</td><td valign="top" align="center">F</td><td valign="top" align="center">R</td><td valign="top" align="left">Left post-central</td><td valign="top" align="left">Word finding difficulty, right hand sensory deficit</td><td valign="top" align="left">GBM</td><td valign="top" align="left">IDH WT, ATRX retained, MGMT methylated</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="center">57</td><td valign="top" align="center">M</td><td valign="top" align="center">R</td><td valign="top" align="left">Left temporal</td><td valign="top" align="left">Seizure</td><td valign="top" align="left">Oligodendroglioma</td><td valign="top" align="left">IDH mt, 1p/19q codeletion</td></tr><tr><td valign="top" align="left">6</td><td valign="top" align="center">32</td><td valign="top" align="center">M</td><td valign="top" align="center">R</td><td valign="top" align="left">Left frontal</td><td valign="top" align="left">Seizure</td><td valign="top" align="left">GBM</td><td valign="top" align="left">IDH mutant, ATRX loss, MGMT methylated</td></tr><tr><td valign="top" align="left">7</td><td valign="top" align="center">55</td><td valign="top" align="center">F</td><td valign="top" align="center">R</td><td valign="top" align="left">Left frontal</td><td valign="top" align="left">Face numbness, right hand incoordination and dysarthria</td><td valign="top" align="left">GBM</td><td valign="top" align="left">IDH WT, p53 positive, MGMT methylated</td></tr><tr><td valign="top" align="left">8</td><td valign="top" align="center">25</td><td valign="top" align="center">F</td><td valign="top" align="center">R</td><td valign="top" align="left">Left frontal</td><td valign="top" align="left">Seizure</td><td valign="top" align="left">Grade II Astrocytoma</td><td valign="top" align="left">IDH mt, ATRX loss, MGMT methylated</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Cluster location and statistics from voxel-wide analysis of Intrinsic Connectivity (IC).</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p>Cluster location and statistics from voxel-wide analysis of Intrinsic Connectivity (IC).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Analysis</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>MNI (x, y, z)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Size (voxels)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Peak <italic>p</italic>-value</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Anatomical location</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>IC</bold></td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">42, 46, 06</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">0.000032</td><td valign="top" align="left" rowspan="1" colspan="1">Right frontal pole</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2</td><td valign="top" align="center" rowspan="1" colspan="1">06, −02, 62</td><td valign="top" align="center" rowspan="1" colspan="1">51</td><td valign="top" align="center" rowspan="1" colspan="1">0.000044</td><td valign="top" align="left" rowspan="1" colspan="1">Right Supplementary Motor Area</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Cluster location and statistics from voxel-wide analysis of Intrinsic Connectivity (IC).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Analysis</th><th valign="top" align="center">Cluster</th><th valign="top" align="center">MNI (x, y, z)</th><th valign="top" align="center">Size (voxels)</th><th valign="top" align="center">Peak p-value</th><th valign="top" align="center">Anatomical location</th></tr></thead><tbody><tr><td valign="top" align="left">IC</td><td valign="top" align="center">1</td><td valign="top" align="center">42, 46, 06</td><td valign="top" align="center">76</td><td valign="top" align="center">0.000032</td><td valign="top" align="left">Right frontal pole</td></tr><tr><td/><td valign="top" align="center">2</td><td valign="top" align="center">06, −02, 62</td><td valign="top" align="center">51</td><td valign="top" align="center">0.000044</td><td valign="top" align="left">Right Supplementary Motor Area</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Future directions for clinical translation.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p>Future directions for clinical translation.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">What is the optimal motor training paradigm for facilitating plasticity of motor networks in glioma patients?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">2</td><td valign="top" align="left" rowspan="1" colspan="1">What are the optimal electrode configurations and stimulation parameters?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">3</td><td valign="top" align="left" rowspan="1" colspan="1">What is the minimum length of time for combined motor training and NIBS to induce long-lasting changes in motor networks?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">4</td><td valign="top" align="left" rowspan="1" colspan="1">Does facilitating plasticity in the preoperative period lead to improved extent of resection?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">5</td><td valign="top" align="left" rowspan="1" colspan="1">Does facilitating plasticity in the preoperative period lead to improved motor outcomes following surgery?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">6</td><td valign="top" align="left" rowspan="1" colspan="1">How does the tumor affect the electric field magnitude within the brain?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">7</td><td valign="top" align="left" rowspan="1" colspan="1">Are there dose-response relationships between electric field magnitude and motor network plasticity?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">8</td><td valign="top" align="left" rowspan="1" colspan="1">What is the best measurement of network reorganization in glioma patients?</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">9</td><td valign="top" align="left" rowspan="1" colspan="1">How does glioma grade and genetics alter response to NIBS?</td></tr></tbody></table><table-wrap-foot><p><italic>NIBS, non-invasive brain stimulation</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Future directions for clinical translation.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td valign="top" align="left">1</td><td valign="top" align="left">What is the optimal motor training paradigm for facilitating plasticity of motor networks in glioma patients?</td></tr><tr><td valign="top" align="left">2</td><td valign="top" align="left">What are the optimal electrode configurations and stimulation parameters?</td></tr><tr><td valign="top" align="left">3</td><td valign="top" align="left">What is the minimum length of time for combined motor training and NIBS to induce long-lasting changes in motor networks?</td></tr><tr><td valign="top" align="left">4</td><td valign="top" align="left">Does facilitating plasticity in the preoperative period lead to improved extent of resection?</td></tr><tr><td valign="top" align="left">5</td><td valign="top" align="left">Does facilitating plasticity in the preoperative period lead to improved motor outcomes following surgery?</td></tr><tr><td valign="top" align="left">6</td><td valign="top" align="left">How does the tumor affect the electric field magnitude within the brain?</td></tr><tr><td valign="top" align="left">7</td><td valign="top" align="left">Are there dose-response relationships between electric field magnitude and motor network plasticity?</td></tr><tr><td valign="top" align="left">8</td><td valign="top" align="left">What is the best measurement of network reorganization in glioma patients?</td></tr><tr><td valign="top" align="left">9</td><td valign="top" align="left">How does glioma grade and genetics alter response to NIBS?</td></tr></tbody></table></div>NIBS, non-invasive brain stimulation.</transformed-table></extracted-table></extracted-tables-set>